echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Cancer Res: A new method for accurate and comprehensive detection of cancer gene fusion events based on long-read sequencing: FusionSeeker

    Cancer Res: A new method for accurate and comprehensive detection of cancer gene fusion events based on long-read sequencing: FusionSeeker

    • Last Update: 2023-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, a research team at the University of Alabama at Birmingham proposed a gene fusion detection tool, FusionSeeker, which can accurately and comprehensively identify gene fusion events in long-reading cancer transcriptome sequencing data and reconstruct accurate fusion transcripts
    from original reads.
    FusionSeeker detects gene fusion tunings based on reads number and filters them to remove noisy signals
    due to sequencing errors and reads alignment errors.
    FusionSeeker has been validated to recognize gene fusions in exon and intron regions, allowing for comprehensive characterization
    of gene fusions in the cancer transcriptome.

    The findings were published in Cancer Research in an article titled "Gene fusion detection and characterization in long-read cancer transcriptome sequencing data with FusionSeeker.
    "

    The research team first benchmarked the accuracy of the FusionSeeker gene fusion detection on a simulated dataset, randomly generating a total of 150 gene fusion transcripts and assigning them to different expression levels
    .
    PacBio Iso-Seq-like and Nanopore-like reads with PBSIM and Badread (v0.
    2.
    0
    simulate, then align to the reference genome
    .
    FusionSeeker and long-chain gene fusion detection tools JAFFAL and LongGF are used to detect gene fusion from simulated reads
    。 The team repeated the simulation three times, and
    FusionSeeker identified more
    true positive events.

    At the same time, FusionSeeker's high recall is mainly due to its ability to detect gene fusions in intron regions, in which FusionSeeker identified 94.
    67%
    of intron events, JAFFAL and LongGF reported 14.
    67% and 54.
    67%,

    respectively.
    Overall, the above three fusion detection tools can achieve higher recall when detecting high and medium expression levels due to fusion
    .
    About 67 percent of the gene fusions lost by FusionSeeker came from the low-expression group due to low reads coverage
    .

    Figure 1: FusionSeeker inspection process

    To generate highly accurate transcript sequences, FusionSeeker performs partial order alignment using reads containing fusions, calculating consistent sequences
    for each gene fusion event.
    In the simulated dataset
    , FusionSeeker reconstructed full-length transcripts of more than 99.
    5%
    of fusion events, using Iso-Seq and Nanopore reads The average sequence recognition rates were 99.
    87%
    and 99.
    14%,

    respectively.
    It is shown that
    FusionSeeker can accurately identify gene fusions and report full-length fusion transcript sequences
    in simulated datasets.

    Next, the research team evaluated the false discovery rates
    of the three tools using the non-cancer dataset of the Human Genome Structural Variation Consortium (HGSVC).
    Of all
    12 non-cancer samples, FusionSeeker reported the lowest number of gene fusions, indicating that FusionSeeker had the lowest rate of false findings among the
    three gene fusion detection tools.
    The research team also
    applied FusionSeeker to the analysis of samples from an acute myeloid leukemia (AML) patient to demonstrate its clinical utility
    .
    Ultimately
    , FusionSeeker identified a pre-validated gene fusion between RUNX1 and RUNX1T1 and reported another 7 in the patient's sample A credible gene fusion event
    .

    Finally, the team evaluated transcript sequences
    generated by FusionSeeker.
    In the Iso-Seq and Nanopore datasets of the MCF-7 cell line compared to the original reads, FusionSeeker The consistency of transcript sequences with reference gene sequences was significantly improved (Figure 2).

    In the
    Iso-Seq dataset of SKBR3 and the Nanopore dataset of the HCT-116 cell line The transcript sequences reported by FusionSeeker were more accurate
    than the original reads.

    Figure 2: FusionSeeker transcript sequence versus reference gene sequence

    In summary, FusionSeeker can detect gene fusions
    in exon and intron regions.
    Based on simulations and data from three cancer cell lines, the study demonstrated that
    FusionSeeker outperforms existing methods
    in detecting gene fusion events.
    In addition, the research team verified many
    gene fusion events
    that were only detected by FusionSeeker through orthogonal and experimental validation.
    These new gene fusions may have important implications for tumor genesis and progression and warrant further study
    .
    Overall
    , FusionSeeker will enable users to accurately discover gene fusions using long-read sequencing data, facilitate downstream functional analysis, and improve cancer diagnosis and treatment
    .

    References:

    Yu Chen, Yiqing Wang, Weisheng Chen,et al.
    Gene fusion detection and characterization in long-read cancer transcriptome sequencing data with FusionSeeker.
    Cancer Res CAN-22-1628.
    2022.
    https://doi.
    org/10.
    1158/0008-5472.
    CAN-22-1628.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.